search
Back to results

Comparison of Rigid and Non-Rigid Interbody Fusion Device for Cervical Degenerative Disc Disease in Adults

Primary Purpose

Cervical Disc Degeneration

Status
Recruiting
Phase
Phase 4
Locations
Taiwan
Study Type
Interventional
Intervention
Z-Brace interbody fusion device
PEEK interbody fusion device
Sponsored by
National Taiwan University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cervical Disc Degeneration focused on measuring Cervical Spine, Interbody Fusion, Anterior Cervical Discectomy and Fusion

Eligibility Criteria

20 Years - 69 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 20 - 69 years;
  2. Symptomatic cervical degenerative disc disease in one or two levels between C3-7 with radiculopathy or myeloradiculopathy and/or decrease muscle strength and/or abnormal sensation and/or abnormal reflexes;
  3. Deficit confirmed by CT, MRI, or X-ray;
  4. NDI Score of โ‰ฅ 30/100;
  5. Unresponsive to non-operative treatment of at least 6 weeks or presence of progressive symptoms or signs of nerve root/spinal cord compression despite continued non-operative treatment;
  6. No prior surgical procedures at the operative level and non-prior fusions at any cervical level;
  7. Physically and mentally able and willing to comply with the protocol;
  8. Signed informed consent;

Exclusion Criteria:

  1. Patient does not meet the indication of Anterior Cervical Discectomy and Fusion (ACDF), which is under the surveillance. (Surgical indication of ACDF is approved by National Health Insurance Administration Ministry of Health and Welfare, a blinded third-party authority).
  2. More than two vertebral levels required surgery;
  3. Immobile levels between C1 and C7 from any cause;
  4. Any prior surgery at the operative level or any prior fusion at any cervical level;
  5. T-score less than -1.5 (osteoporosis evaluation)
  6. Paget's disease, osteomalacia, or any other metabolic bone disease other than osteoporosis;
  7. Active infection of surgical site or history of anticipated treatment for systemic infection including HIV
  8. Active malignancy: a history of any invasive malignancy (except carcinoma in situ and non-melanoma skin cancer), unless treated with curative intent with no clinical signs or symptoms of malignancy in the past 5 years;
  9. Marked instability of the cervical spine on resting lateral or flexion-extension radiographs;
  10. Known allergy to device materials including titanium or polyetheretherketone (PEEK);
  11. Segmental kyphosis of greater than 11 degrees at treatment or adjacent levels
  12. Rheumatoid arthritis, lupus, or other autoimmune disease;
  13. Any diseases or conditions that would preclude accurate clinical evaluation;
  14. Daily, high-dose oral and/or inhaled steroid or a history of chronic use of high dose steroids;
  15. Body Mass Index (BMI) > 35
  16. Smoking more than one pack of cigarettes per day;

Sites / Locations

  • Chung Shan Medical University HospitalRecruiting
  • Fu Jen Catholic University HospitalRecruiting
  • Taipei Municipal Wan Fang Hospital
  • National Taiwan University Hospital Yunlin BranchRecruiting
  • Taipei Medical University-Shuang Ho Hospital,Ministry of Health and WelfareRecruiting
  • MacKay Memorial HospitalRecruiting
  • National Taiwan University HospitalRecruiting
  • National Taiwan University Hospital Hsin-Chu BranchRecruiting
  • China Medical University HospitalRecruiting
  • Jen-Ai Hospital Dali BranchRecruiting
  • National Cheng Kung University Hospital
  • Min-Sheng General HospitalRecruiting
  • Chang Gung Memorial Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Investigational device (non-rigid) group

Control device (rigid) group

Arm Description

Use non-rigid (Titanium Alloy, Z-Brace, Baui Biotech) interbody fusion device.

Use rigid (PEEK) interbody fusion device .

Outcomes

Primary Outcome Measures

Change from baseline postoperative condition (if patients have major complications)
No adverse events (AEs) classified as major complications by Research Ethics Committee.
Change from baseline postoperative condition (if patients have subsequent surgeries)
No subsequent surgical intervention.
Change from baseline Subsidence and Fusion rate
Subsidence and fusion rate on radiological.
Change from baseline Adjacent range of motion
Adjacent range of motion on radiological.
Change from baseline Neck Disability Index (NDI)
An improvement in Neck Disability Index (NDI) score of at least 30 points for a patient with a preoperative NDI score of 60 or greater; or an improvement of at least 50% of preoperative NDI score for patients with a preoperative score of less than 60.

Secondary Outcome Measures

Visual analogue scale (neck and arm and chest pain)
Patient will be evaluated by Visual analogue scale(VAS) for their neck, arm and chest pain. The minimum value is 0 and the maximum value is 10. Higher score means a worse outcome.
Patient Satisfaction Questionnaire
Patients will be surveyed by Patient Satisfaction Questionnaire. There are two questions on the questionnaire to evaluate if they are satisfied with their treatment and if they will recommend their respective surgery to a friend.
Anxiety score
The Beck Anxiety Inventory (BAI). The minimum value is 0 and the maximum value is 63. Higher scores mean a worse outcome.
Short form-12 mental component scale and physical component scale (SF-12 MCS/PCS) score
Short form-12 mental component scale and physical component scale. The minimum value of physical component scale (PCS-12) is 18.4 and the maximum value of PCS-12 is 57.8. The minimum value of mental component scale (MCS-12) is 18.7 and the maximum value of MCS-12 is 65.2. Higher scores mean a better outcome.
Number of days using Non-steroidal anti-inflammatory analgesics(NSAIDs)
Number of days using Non-steroidal anti-inflammatory analgesics(NSAIDs)
Depression Score
Beck Depression Inventory(BDI). The minimum value is 0 and the maximum value is 63. Higher scores mean a worse outcome.

Full Information

First Posted
September 2, 2020
Last Updated
July 31, 2023
Sponsor
National Taiwan University Hospital
Collaborators
Baui Biotech Co., Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT04550923
Brief Title
Comparison of Rigid and Non-Rigid Interbody Fusion Device for Cervical Degenerative Disc Disease in Adults
Official Title
Comparison of Rigid and Non-Rigid Interbody Fusion Device for Cervical Degenerative Disc Disease in Adults - A Randomized, Prospective, Multicenter Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 3, 2020 (Actual)
Primary Completion Date
June 30, 2023 (Actual)
Study Completion Date
June 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital
Collaborators
Baui Biotech Co., Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Rigid interbody fusion device in bulk configuration has been widely used in anterior cervical discectomy and fusion (ACDF) surgery. It is a randomized, prospective, multicenter clinical study to compare rigid and non-rigid fusion device in ACDF for cervical degenerative disc disease.
Detailed Description
This study is a randomized, prospective, multicenter clinical trial comparing rigid (PEEK) interbody fusion device with non-rigid (Titanium Alloy, Z-Brace, Baui Biotech) interbody fusion device in ACDF surgery at 11 clinical sites. ACDF was performed with stand-alone interbody fusion device and artificial bone graft (hydroxyapatite/tricalcium phosphate). Patients have 1-level or 2-level cervical degenerative disc disease approved for ACDF surgery by National Health Insurance, which is the blind, third-party, administrative approved and insurance reimbursement for surgical indication. Total 180 patients were enrolled, and 180 patients were randomized into either investigational device (non-rigid) group or the control (rigid) group in a 2:1 ratio. After confirming a patient's eligibility and having the patient sign an informed consent form, the site investigator or study coordinator call the coordinator at National Taiwan University Hospital for the randomization. Each patient will be then assigned to 1 of the treatment group according to a randomized schedule. Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively. Measured outcomes included overall success, Neck Disability Index (NDI), VAS neck and arm pain, adjacent range of motion, patient satisfaction, anxiety score, SF-12 MCS/PCS, major complications, subsequent surgery rate, and subsidence and fusion rate on radiological examinations. The primary endpoint was a FDA composite definition of success comprising clinical improvement and absence of major complications and secondary surgery events.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Disc Degeneration
Keywords
Cervical Spine, Interbody Fusion, Anterior Cervical Discectomy and Fusion

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Total 180 patients were enrolled, and 180 patients were randomized into either investigational device (non-rigid) group or the control (rigid) group in a 2:1 ratio.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
180 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Investigational device (non-rigid) group
Arm Type
Experimental
Arm Description
Use non-rigid (Titanium Alloy, Z-Brace, Baui Biotech) interbody fusion device.
Arm Title
Control device (rigid) group
Arm Type
Active Comparator
Arm Description
Use rigid (PEEK) interbody fusion device .
Intervention Type
Combination Product
Intervention Name(s)
Z-Brace interbody fusion device
Intervention Description
Use non-rigid (Titanium Alloy, Z-Brace, Baui Biotech) interbody fusion device in Anterior Cervical Discectomy and Fusion (ACDF) surgery
Intervention Type
Combination Product
Intervention Name(s)
PEEK interbody fusion device
Intervention Description
Use rigid (PEEK) interbody fusion device in Anterior Cervical Discectomy and Fusion (ACDF) surgery
Primary Outcome Measure Information:
Title
Change from baseline postoperative condition (if patients have major complications)
Description
No adverse events (AEs) classified as major complications by Research Ethics Committee.
Time Frame
Patient were evaluated one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Change from baseline postoperative condition (if patients have subsequent surgeries)
Description
No subsequent surgical intervention.
Time Frame
Patient were evaluated one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Change from baseline Subsidence and Fusion rate
Description
Subsidence and fusion rate on radiological.
Time Frame
Patient were evaluated one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Change from baseline Adjacent range of motion
Description
Adjacent range of motion on radiological.
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Change from baseline Neck Disability Index (NDI)
Description
An improvement in Neck Disability Index (NDI) score of at least 30 points for a patient with a preoperative NDI score of 60 or greater; or an improvement of at least 50% of preoperative NDI score for patients with a preoperative score of less than 60.
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Secondary Outcome Measure Information:
Title
Visual analogue scale (neck and arm and chest pain)
Description
Patient will be evaluated by Visual analogue scale(VAS) for their neck, arm and chest pain. The minimum value is 0 and the maximum value is 10. Higher score means a worse outcome.
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Patient Satisfaction Questionnaire
Description
Patients will be surveyed by Patient Satisfaction Questionnaire. There are two questions on the questionnaire to evaluate if they are satisfied with their treatment and if they will recommend their respective surgery to a friend.
Time Frame
Patient were evaluated one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Anxiety score
Description
The Beck Anxiety Inventory (BAI). The minimum value is 0 and the maximum value is 63. Higher scores mean a worse outcome.
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Short form-12 mental component scale and physical component scale (SF-12 MCS/PCS) score
Description
Short form-12 mental component scale and physical component scale. The minimum value of physical component scale (PCS-12) is 18.4 and the maximum value of PCS-12 is 57.8. The minimum value of mental component scale (MCS-12) is 18.7 and the maximum value of MCS-12 is 65.2. Higher scores mean a better outcome.
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Number of days using Non-steroidal anti-inflammatory analgesics(NSAIDs)
Description
Number of days using Non-steroidal anti-inflammatory analgesics(NSAIDs)
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.
Title
Depression Score
Description
Beck Depression Inventory(BDI). The minimum value is 0 and the maximum value is 63. Higher scores mean a worse outcome.
Time Frame
Patient were evaluated preoperatively, one month postoperatively, and 3, 6, 12, 18, and 24 months postoperatively.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 20 - 69 years; Symptomatic cervical degenerative disc disease in one or two levels between C3-7 with radiculopathy or myeloradiculopathy and/or decrease muscle strength and/or abnormal sensation and/or abnormal reflexes; Deficit confirmed by CT, MRI, or X-ray; NDI Score of โ‰ฅ 30/100; Unresponsive to non-operative treatment of at least 6 weeks or presence of progressive symptoms or signs of nerve root/spinal cord compression despite continued non-operative treatment; No prior surgical procedures at the operative level and non-prior fusions at any cervical level; Physically and mentally able and willing to comply with the protocol; Signed informed consent; Exclusion Criteria: Patient does not meet the indication of Anterior Cervical Discectomy and Fusion (ACDF), which is under the surveillance. (Surgical indication of ACDF is approved by National Health Insurance Administration Ministry of Health and Welfare, a blinded third-party authority). More than two vertebral levels required surgery; Immobile levels between C1 and C7 from any cause; Any prior surgery at the operative level or any prior fusion at any cervical level; T-score less than -1.5 (osteoporosis evaluation) Paget's disease, osteomalacia, or any other metabolic bone disease other than osteoporosis; Active infection of surgical site or history of anticipated treatment for systemic infection including HIV Active malignancy: a history of any invasive malignancy (except carcinoma in situ and non-melanoma skin cancer), unless treated with curative intent with no clinical signs or symptoms of malignancy in the past 5 years; Marked instability of the cervical spine on resting lateral or flexion-extension radiographs; Known allergy to device materials including titanium or polyetheretherketone (PEEK); Segmental kyphosis of greater than 11 degrees at treatment or adjacent levels Rheumatoid arthritis, lupus, or other autoimmune disease; Any diseases or conditions that would preclude accurate clinical evaluation; Daily, high-dose oral and/or inhaled steroid or a history of chronic use of high dose steroids; Body Mass Index (BMI) > 35 Smoking more than one pack of cigarettes per day;
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dar-Ming Lai
Phone
+886-2312-3456
Ext
65078
Email
dmlai@ntu.edu.tw
First Name & Middle Initial & Last Name or Official Title & Degree
Fon-Yih Tsuang
Phone
+886-972651142
Email
tsuangfy@gmail.com
Facility Information:
Facility Name
Chung Shan Medical University Hospital
City
Taichung
State/Province
South Dist.
ZIP/Postal Code
402
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Se-Yi Chen
First Name & Middle Initial & Last Name & Degree
Se-Yi Chen
Facility Name
Fu Jen Catholic University Hospital
City
New Taipei City
State/Province
Taishan District
ZIP/Postal Code
243
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wei-Lung Tseng
Phone
+886-905301906
Email
puddingj@gmail.com
First Name & Middle Initial & Last Name & Degree
Wei-Lung Tseng
Facility Name
Taipei Municipal Wan Fang Hospital
City
Taipei City
State/Province
Wenshan Dist.
ZIP/Postal Code
116
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yi-Jie Kuo
Email
benkuo5@tmu.edu.tw
First Name & Middle Initial & Last Name & Degree
Ming-Hong Chen
First Name & Middle Initial & Last Name & Degree
Yi-Jie Kuo
First Name & Middle Initial & Last Name & Degree
Ming-Hong Chen
Facility Name
National Taiwan University Hospital Yunlin Branch
City
Douliu
State/Province
Yunlin County
ZIP/Postal Code
640
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yuan-Sen Chen
Phone
+886-5-5323911
First Name & Middle Initial & Last Name & Degree
Yuan-Sen Chen
Facility Name
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare
City
New Taipei
State/Province
Zhonghe District
ZIP/Postal Code
23561
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chang-Jung Chiang
First Name & Middle Initial & Last Name & Degree
Chang-Jung Chiang
Facility Name
MacKay Memorial Hospital
City
Taipei City
State/Province
Zhongshan
ZIP/Postal Code
10449
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hsu-Chao Chen
Phone
+886-936099219
Email
chenshiujau@gmail.com
First Name & Middle Initial & Last Name & Degree
Hsu-Chao Chen
Facility Name
National Taiwan University Hospital
City
Taipei
State/Province
Zhongzheng Dist.
ZIP/Postal Code
100
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dar-Ming Lai
Phone
+88623123456
Ext
65078
Email
dmlai@ntu.edu.tw
First Name & Middle Initial & Last Name & Degree
Fon-Yih Tsuang
Phone
+886972651142
Email
tsuangfy@gmail.com
First Name & Middle Initial & Last Name & Degree
Dar-Ming Lai
First Name & Middle Initial & Last Name & Degree
Fon-Yih Tsuang
First Name & Middle Initial & Last Name & Degree
Furen Xiao
First Name & Middle Initial & Last Name & Degree
Shih-Hung Yang
Facility Name
National Taiwan University Hospital Hsin-Chu Branch
City
Hsinchu
ZIP/Postal Code
300
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Huan-Chih Wang
Phone
+886-972654379
Email
jessehcwang@ntu.edu.tw
First Name & Middle Initial & Last Name & Degree
Huan-Chih Wang
Facility Name
China Medical University Hospital
City
Taichung
ZIP/Postal Code
404332
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chao-Hsuan Chen
Phone
+886-4-22052121
First Name & Middle Initial & Last Name & Degree
Sung-Tai Wei
Phone
+886-4-22052121
First Name & Middle Initial & Last Name & Degree
Chao-Hsuan Chen
First Name & Middle Initial & Last Name & Degree
Sung-Tai Wei
Facility Name
Jen-Ai Hospital Dali Branch
City
Taichung
ZIP/Postal Code
412
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yu-Tung Shih
First Name & Middle Initial & Last Name & Degree
Yu-Tung Shih
Facility Name
National Cheng Kung University Hospital
City
Tainan
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cheng-Li Lin
First Name & Middle Initial & Last Name & Degree
Cheng-Li Lin
Facility Name
Min-Sheng General Hospital
City
Taoyuan
ZIP/Postal Code
330
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shao Hua Ko
Phone
+886-975082212
Email
M002013@e-ms.com.tw
First Name & Middle Initial & Last Name & Degree
Ming Yuan Chang
Phone
+886-966500038
Email
arynancha@gmail.com
First Name & Middle Initial & Last Name & Degree
Ming Yuan Chang
First Name & Middle Initial & Last Name & Degree
Shao-Hua Ko
Facility Name
Chang Gung Memorial Hospital
City
Taoyuan
Country
Taiwan
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yu-Cheng Yeh
Phone
03-319-6200
First Name & Middle Initial & Last Name & Degree
Yu-Cheng Yeh
First Name & Middle Initial & Last Name & Degree
Po-Liang Lai

12. IPD Sharing Statement

Citations:
PubMed Identifier
12897467
Citation
Zdeblick TA, Phillips FM. Interbody cage devices. Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S2-7. doi: 10.1097/01.BRS.0000076841.93570.78.
Results Reference
background
PubMed Identifier
1440038
Citation
Brodke DS, Zdeblick TA. Modified Smith-Robinson procedure for anterior cervical discectomy and fusion. Spine (Phila Pa 1976). 1992 Oct;17(10 Suppl):S427-30. doi: 10.1097/00007632-199210001-00014.
Results Reference
background
PubMed Identifier
25982430
Citation
Shriver MF, Lewis DJ, Kshettry VR, Rosenbaum BP, Benzel EC, Mroz TE. Pseudoarthrosis rates in anterior cervical discectomy and fusion: a meta-analysis. Spine J. 2015 Sep 1;15(9):2016-27. doi: 10.1016/j.spinee.2015.05.010. Epub 2015 May 15.
Results Reference
background
PubMed Identifier
8408151
Citation
Bohlman HH, Emery SE, Goodfellow DB, Jones PK. Robinson anterior cervical discectomy and arthrodesis for cervical radiculopathy. Long-term follow-up of one hundred and twenty-two patients. J Bone Joint Surg Am. 1993 Sep;75(9):1298-307. doi: 10.2106/00004623-199309000-00005.
Results Reference
background
PubMed Identifier
19262984
Citation
Sugawara T, Itoh Y, Hirano Y, Higashiyama N, Mizoi K. Long term outcome and adjacent disc degeneration after anterior cervical discectomy and fusion with titanium cylindrical cages. Acta Neurochir (Wien). 2009 Apr;151(4):303-9; discussion 309. doi: 10.1007/s00701-009-0217-5. Epub 2009 Mar 5.
Results Reference
background
PubMed Identifier
18846395
Citation
Elsawaf A, Mastronardi L, Roperto R, Bozzao A, Caroli M, Ferrante L. Effect of cervical dynamics on adjacent segment degeneration after anterior cervical fusion with cages. Neurosurg Rev. 2009 Apr;32(2):215-24; discussion 224. doi: 10.1007/s10143-008-0164-2. Epub 2008 Oct 10.
Results Reference
background
PubMed Identifier
17221174
Citation
Barsa P, Suchomel P. Factors affecting sagittal malalignment due to cage subsidence in standalone cage assisted anterior cervical fusion. Eur Spine J. 2007 Sep;16(9):1395-400. doi: 10.1007/s00586-006-0284-8. Epub 2007 Jan 13.
Results Reference
background
PubMed Identifier
15260088
Citation
Goffin J, Geusens E, Vantomme N, Quintens E, Waerzeggers Y, Depreitere B, Van Calenbergh F, van Loon J. Long-term follow-up after interbody fusion of the cervical spine. J Spinal Disord Tech. 2004 Apr;17(2):79-85. doi: 10.1097/00024720-200404000-00001.
Results Reference
background
PubMed Identifier
10436851
Citation
Maiman DJ, Kumaresan S, Yoganandan N, Pintar FA. Biomechanical effect of anterior cervical spine fusion on adjacent segments. Biomed Mater Eng. 1999;9(1):27-38.
Results Reference
background
PubMed Identifier
3775422
Citation
Gore DR, Gardner GM, Sepic SB, Murray MP. Roentgenographic findings following anterior cervical fusion. Skeletal Radiol. 1986;15(7):556-9. doi: 10.1007/BF00361055.
Results Reference
background
PubMed Identifier
30415055
Citation
Gao X, Yang Y, Liu H, Meng Y, Zeng J, Wu T, Hong Y. A Comparison of Cervical Disc Arthroplasty and Anterior Cervical Discectomy and Fusion in Patients with Two-Level Cervical Degenerative Disc Disease: 5-Year Follow-Up Results. World Neurosurg. 2019 Feb;122:e1083-e1089. doi: 10.1016/j.wneu.2018.10.231. Epub 2018 Nov 9.
Results Reference
background
PubMed Identifier
27771787
Citation
Ma Z, Ma X, Yang H, Guan X, Li X. Anterior cervical discectomy and fusion versus cervical arthroplasty for the management of cervical spondylosis: a meta-analysis. Eur Spine J. 2017 Apr;26(4):998-1008. doi: 10.1007/s00586-016-4779-7. Epub 2016 Oct 22.
Results Reference
background
PubMed Identifier
27295435
Citation
Kuang L, Chen Y, Wang B, Li L, Lu G. Cervical Disk Arthroplasty Versus Anterior Cervical Decompression and Fusion for the Treatment of 2-Level Cervical Spondylopathy: A Systematic Review and Meta-analysis. Clin Spine Surg. 2016 Nov;29(9):372-382. doi: 10.1097/BSD.0000000000000395.
Results Reference
background
PubMed Identifier
26872258
Citation
Hu Y, Lv G, Ren S, Johansen D. Mid- to Long-Term Outcomes of Cervical Disc Arthroplasty versus Anterior Cervical Discectomy and Fusion for Treatment of Symptomatic Cervical Disc Disease: A Systematic Review and Meta-Analysis of Eight Prospective Randomized Controlled Trials. PLoS One. 2016 Feb 12;11(2):e0149312. doi: 10.1371/journal.pone.0149312. eCollection 2016.
Results Reference
background
PubMed Identifier
22960519
Citation
Ding D, Shaffrey ME. Cervical disk arthroplasty: patient selection. Clin Neurosurg. 2012;59:91-7. doi: 10.1227/NEU.0b013e31826b6fbe. No abstract available.
Results Reference
background
PubMed Identifier
19468885
Citation
Jaramillo-de la Torre JJ, Grauer JN, Yue JJ. Update on cervical disc arthroplasty: where are we and where are we going? Curr Rev Musculoskelet Med. 2008 Jun;1(2):124-30. doi: 10.1007/s12178-008-9019-2.
Results Reference
background
PubMed Identifier
28057595
Citation
Tahal D, Madhavan K, Chieng LO, Ghobrial GM, Wang MY. Metals in Spine. World Neurosurg. 2017 Apr;100:619-627. doi: 10.1016/j.wneu.2016.12.105. Epub 2017 Jan 3.
Results Reference
background
PubMed Identifier
31528438
Citation
Epstein NE. A Review of Complication Rates for Anterior Cervical Diskectomy and Fusion (ACDF). Surg Neurol Int. 2019 Jun 7;10:100. doi: 10.25259/SNI-191-2019. eCollection 2019.
Results Reference
background
PubMed Identifier
12188968
Citation
Goffin J, Casey A, Kehr P, Liebig K, Lind B, Logroscino C, Pointillart V, Van Calenbergh F, van Loon J. Preliminary clinical experience with the Bryan Cervical Disc Prosthesis. Neurosurgery. 2002 Sep;51(3):840-5; discussion 845-7. doi: 10.1227/00006123-200209000-00048.
Results Reference
background
Links:
URL
https://doi.org/10.1016/S1359-6454(98)80035-9
Description
W. Bonfield MW, K.E. Tanner. Interfaces in analogue biomaterials. Acta Materialia. 1998;46๏ผˆ7๏ผ‰:2509-18.

Learn more about this trial

Comparison of Rigid and Non-Rigid Interbody Fusion Device for Cervical Degenerative Disc Disease in Adults

We'll reach out to this number within 24 hrs